Search Results 501-510 of 17661 for corticosteroid

  1. Nephrotic syndrome - Diagnosis & treatment - Mayo Clinic

    Medications to control the immune system, such as corticosteroids, can decrease the inflammation that accompanies some of the conditions that can cause ...

  2. Neuromyelitis optica - Diagnosis and treatment - Mayo Clinic

    Treatment · Reversing recent symptoms. In the early stage of an NMO attack, a health care provider might give a corticosteroid medicine such as ...

  3. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 7 days of study drug administration. Inhaled or

  4. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    ... corticosteroid and/or calcineurin inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the ...

  5. A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease - Mayo Clinic

    ... corticosteroid) for the treatment of TED is allowed if the corticosteroid is discontinued at least 6 weeks before screening. -Systemic (oral or IV) ...

  6. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    ... corticosteroids (OCS) ≤ 4mg/day) at ... * Participants receiving any of the following: Oral corticosteroids: Participant requires an oral corticosteroid ...

  7. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

    Corticosteroid use ≤ 14 days prior to registration;. NOTE: Patients must be off systemic corticosteroids for at least 2 weeks prior to registration. This ...

  8. Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma - Mayo Clinic

    ... corticosteroid (ICS). The low-dose ICS may be either as ICS monotherapy or as an ICS/long-acting beta agonist (LABA) combination. The ICS component of the ...

  9. Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease - Mayo Clinic

    - Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or corticosteroid therapy are also eligible. Exclusion Criteria ...

  10. Niraparib + TSR042 In BRCA Mutated Breast Cancer - Mayo Clinic

    corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment. - Patients with a history ...